Novel therapies to augment neurological benefits of cellular therapies for traumatic spinal cord injury

增强细胞疗法治疗创伤性脊髓损伤神经学益处的新疗法

• 批准号: 369844
• 负责人: Karimi-Abdolrezaee Soheila
• 金额: $ 77.19万
• 依托单位: University of Manitoba
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=369844&lang=en
• 关键词: Combinatorial Drug And Stem Cell Delivery; Matrix And Glial Scar; Motor And Sensroy Assessments; Myelin Repair; Neuroanaotmy And Imaging; Neuroinflammation; Neurological Recovery; Oxidative Stress And Cell Death; Preclinical Interventions; Spinal Cord Inj

Spinal cord injury (SCI) is a leading cause of permanent neurological disabilities affecting over 2.5 million individuals worldwide. In Canada, there are over 86,000 patients who are afflicted with lifelong consequences of SCI with approximately 4,200 new

脊髓损伤 (SCI) 是造成永久性神经功能障碍的主要原因，影响着全球超过 250 万人。在加拿大，有超过 86,000 名患者受到 SCI 的终生影响，其中约 4,200 名新患者